Stay updated with breaking news from 91307c10. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Daiwa Securities Group Inc. raised its position in shares of United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 1,530.1% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 2,983 shares of the biotechnology company’s stock after buying an additional 2,800 shares […]
United Therapeutics Co. (NASDAQ:UTHR – Get Free Report) EVP Paul A. Mahon sold 2,500 shares of the stock in a transaction that occurred on Thursday, July 20th. The stock was sold at an average price of $243.87, for a total value of $609,675.00. Following the sale, the executive vice president now directly owns 36,599 shares […]
United Therapeutics Co. (NASDAQ:UTHR – Get Free Report) EVP Paul A. Mahon sold 2,500 shares of United Therapeutics stock in a transaction dated Thursday, July 20th. The stock was sold at an average price of $243.87, for a total value of $609,675.00. Following the completion of the transaction, the executive vice president now directly owns […]
Pacer Advisors Inc. boosted its stake in shares of United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 1,567.0% during the first quarter, Holdings Channel.com reports. The firm owned 172,101 shares of the biotechnology company’s stock after purchasing an additional 161,777 shares during the quarter. Pacer Advisors Inc.’s holdings in United Therapeutics were worth $38,544,000 as […]
United Therapeutics (NASDAQ:UTHR – Get Free Report) was upgraded by analysts at StockNews.com from a “buy” rating to a “strong-buy” rating in a note issued to investors on Wednesday. A number of other equities analysts have also recently issued reports on UTHR. UBS Group dropped their target price on United Therapeutics from $330.00 to $310.00 […]